Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.)

Scopus

Scopus profile and journal metrics

This journal is indexed in Scopus. Use these metrics for a quick publishing snapshot, then open the Scopus page for the authoritative profile.

Scopus
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Indexed in Scopus since 2022
CiteScore 1.0
Indexed since 2022
First decision 7 Days
Submission to acceptance 45 Days
Acceptance to publication 14 Days
Acceptance rate 8%

SCImago

SCImago Journal Rank preview

Use SCImago when you want a quick visual view of the journal ranking profile and external discoverability signals.

Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) SCImago Journal & Country Rank

DOAJ

Directory of Open Access Journals listing

The DOAJ record is useful for readers, librarians, and authors who want a direct open-access directory entry for the journal.

DOAJ
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Open directory record
Original full research article

Familial versus sporadic multiple sclerosis in Palestine: a retrospective cross-sectional pilot study

Published
2021-12-06
Pages
7 - 16
Full text

Keywords

  • Multiple Sclerosis
  • Sporadic
  • Consanguinity

Abstract

Background: Multiple sclerosis (MS) is a prevalent multifactorial neurological condition caused by hereditary and environmental factors. No research in Palestine has focused on family instances and the likely influence of paternal consanguinity (PC). In this study, re-searchers evaluated numerous risk variables, clinical course, early symptoms, and disability prevalence in familial MS (FMS) cases and sporadic MS (SMS) cases in the Palestinian com-munity. Methods: A suitable sample of 90 SMS and 31 FMS patients was used in a retrospec-tive cross-sectional analysis. Neurology clinics provided the data. Data were examined using IBM SPSS 22 to compare FMS with SMS in numerous risk factors, clinical course, early symptoms, and disability prevalence. Results: The research included 90 SMS instances and 31 FMS cases. Males developed FMS at a higher rate (45.2 %) than females (35 %) in the SMS group. In contrast, more females (64.4 %) had SMS than men (54.8 %) in the FMS group. However, ladies were more likely than men to have any MS. Parental consanguinity was identified in around 40% of the SMS and FMS groups. The mean age of onset was the same in both groups (28.5 in SMS and 27.26 in FMS), and practically all patients in both groups had recurrent MS episodes. There is no statistically significant difference between SMS and FMS regarding risk factors and lifestyle variables. Only within the SMS was the oc-currence of autoimmune disorders mentioned. Within the two groups, the relapsing-remitting clinical course predominates. The proportion of first presenting symptoms and impairments did not differ substantially between the SMS and FMS. Conclusion: There were no significant variations between SMS and FMS regarding demographics, risk factors, disability, clinical course, and PC.

Article history

Received
2021-10-11
Accepted
2021-12-06
بحث أصيل كامل

Familial versus sporadic multiple sclerosis in Palestine: a retrospective cross-sectional pilot study

Published
2021-12-06
الصفحات
7 - 16
البحث كاملا

الكلمات الإفتتاحية

  • Multiple Sclerosis
  • Sporadic
  • Consanguinity

الملخص

Background: Multiple sclerosis (MS) is a prevalent multifactorial neurological condition caused by hereditary and environmental factors. No research in Palestine has focused on family instances and the likely influence of paternal consanguinity (PC). In this study, re-searchers evaluated numerous risk variables, clinical course, early symptoms, and disability prevalence in familial MS (FMS) cases and sporadic MS (SMS) cases in the Palestinian com-munity. Methods: A suitable sample of 90 SMS and 31 FMS patients was used in a retrospec-tive cross-sectional analysis. Neurology clinics provided the data. Data were examined using IBM SPSS 22 to compare FMS with SMS in numerous risk factors, clinical course, early symptoms, and disability prevalence. Results: The research included 90 SMS instances and 31 FMS cases. Males developed FMS at a higher rate (45.2 %) than females (35 %) in the SMS group. In contrast, more females (64.4 %) had SMS than men (54.8 %) in the FMS group. However, ladies were more likely than men to have any MS. Parental consanguinity was identified in around 40% of the SMS and FMS groups. The mean age of onset was the same in both groups (28.5 in SMS and 27.26 in FMS), and practically all patients in both groups had recurrent MS episodes. There is no statistically significant difference between SMS and FMS regarding risk factors and lifestyle variables. Only within the SMS was the oc-currence of autoimmune disorders mentioned. Within the two groups, the relapsing-remitting clinical course predominates. The proportion of first presenting symptoms and impairments did not differ substantially between the SMS and FMS. Conclusion: There were no significant variations between SMS and FMS regarding demographics, risk factors, disability, clinical course, and PC.

Article history

تاريخ التسليم
2021-10-11
تاريخ القبول
2021-12-06